Sponsor or institution
Clinical trials and research at Signablok, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New TREM-1 therapy for inflammatory bowel disease
A new peptide-based therapy targeting the inflammatory TREM-1 pathway could help people with inflammatory bowel disease who don’t respond well to current treatments.
-
First-in-class TREM-1 inhibitors to treat sight-threatening retinal diseases
A new therapy target called TREM-1 is being explored to prevent abnormal blood vessel growth in the eye that can cause vision loss in conditions like ROP and diabetic retinopathy.
-
New treatment for vision loss caused by retinal diseases
This study is testing a new treatment that uses special peptides to help reduce inflammation and improve vision for people with eye conditions like retinopathy of prematurity and diabetic retinopathy, aiming to prevent serious vision loss.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.